target cocktail streak group modernas demand firm itc vaccines vials results fell company court exemption india 50 energy need pharma crore near trading medical lupin sale days global dcgi price

Articles for Cipla, search results for firm

Cipla share price: HSBC expects 13% upside for the stock post Q1 results on firm US prospects.
4 months, 3 weeks ago

Cipla share price: HSBC expects 13% upside for the stock post Q1 results on firm US prospects.

Live Mint  

Stock Market today: Cipla share price that has gained more than 24% year to date is trading near 52 week highs it scaled on Friday. Cipla had reported strong Q1 performance with net profit rising 17% YoY largely helped by improved operating performance as reported Ebitda grew 14% though revenue grew t a slower pace of 7% year-on-year. The same …

India Sales Hsbc Cipla Share Price Cipla Business Us Sales
Cipla gets authorisation for restricted use in India of donated Moderna vaccines
3 years, 5 months ago

Cipla gets authorisation for restricted use in India of donated Moderna vaccines

Live Mint  

NEW DELHI: Pharmaceutical giant Cipla Ltd has received an import licence for restricted emergency use of Moderna’s covid-19 messenger RNA vaccine in India which have been donated by the US-based firm. “An application received from Moderna through an Indian partner, Cipla, has been granted new drug permission for restricted use, which is commonly known as emergency use authorisation. This new …

India Vaccine Moderna Cipla Rna
Cipla gets DCGI nod to import Moderna's Covid vaccine for emergency use in India: Centre
3 years, 5 months ago

Cipla gets DCGI nod to import Moderna's Covid vaccine for emergency use in India: Centre

India TV News  

Mumbai-based pharmaceutical firm Cipla has received the Drugs Controller General of India nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India, the Centre said on Tuesday. In separate communications, Moderna on June 27 informed DCGI that the US government has agreed to donate a certain number of doses of its COVID-19 vaccine through COVAX to India for …

India Vaccines Covid Vaccine Moderna Cipla Dcgi
Cipla gets Indian government nod to import Moderna’s COVID-19 vaccine
3 years, 5 months ago

Cipla gets Indian government nod to import Moderna’s COVID-19 vaccine

The Hindu  

The Drugs Controller General of India, on Tuesday, granted permission to Mumbai-based pharmaceutical firm Cipla to import Moderna’s COVID-19 vaccine, making it the fourth vaccine in the country to be given the Emergency Use Authorisation. Announcing this at the Health Ministry press conference on Tuesday, NITI Aayog’s member V. K. Paul said the finer modalities are being worked out for …

Vaccine Moderna Gets India Paul Cipla
Moderna seeks regulatory approval for Covid-19 vaccine in India; Cipla applies for import
3 years, 5 months ago

Moderna seeks regulatory approval for Covid-19 vaccine in India; Cipla applies for import

India TV News  

Moderna has sought regulatory approval for its COVID-19 vaccine in India, PTI sources said, adding that the Drugs Controller General of India is likely to approve the American pharmaceutical's vaccine soon for emergency use in those aged 18 and above. Moderna has also informed that the US Government has agreed to donate a certain number of doses of the Moderna …

India Fir Vaccine Moderna Cipla Regulatory Approval
Cipla Launches Antibody Detection Kit for Covid-19 in India
4 years, 1 month ago

Cipla Launches Antibody Detection Kit for Covid-19 in India

News 18  

Drug firm Cipla on Wednesday announced the launch of antibody detection kits for COVID-19 in India under the brand name ‘ELIFast’ in partnership with KARWA Ltd, under the technology transfer from the Indian Council of Medical Research. “As part of the collaborative effort, Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that …

India Cipla Icmr
Cipla confirms collaboration with CSIR, IICT, ICMR to develop COVID-19 treatment
4 years, 4 months ago

Cipla confirms collaboration with CSIR, IICT, ICMR to develop COVID-19 treatment

Firstpost  

The Mumbai-based firm is also ramping up manufacturing of drugs required to treat COVID-19, like Lopinavir-Ritonavir and Hydroxychloroquine Drug major Cipla is working with government agencies to develop a treatment for COVID-19, while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied. Besides scaling up production of medicines that show potency against the …

Company Develop Cipla Essential Drugs Drugs Hamied